Core Scientific Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Adam Sullivan

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	4.9yrs
Gemiddelde ambtstermijn bestuur	2yrs

Recente managementupdates

Recent updates

Core Scientific: A Solid Bitcoin Mining Play

Oct 11

Core Scientific: A Buy On Leading Bitcoin Production Numbers

Aug 11

Core Scientific July bitcoin production rose 10.4% M/M with new deployments and multiple facilities

Aug 05

Core Scientific signs $100M in committed equity facility for enhancing liquidity

Jul 21

Why I'm Very Optimistic On Core Scientific's Future

Jun 10

Robust Earnings May Not Tell The Whole Story For Core Scientific (NASDAQ:CORZ)

Apr 10

CEO

Adam Sullivan (32 yo)

less than a year

Tenure

Mr. Adam Sullivan serves as President of Core Scientific, Inc. since May 15, 2023 and is Chief Executive Officer from August 2023. He was a Managing Director and Head of Digital Assets and Infrastructure G...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Darin Feinstein	Co-Founder & Executive VP of Corporate Strategy & Director	no data	geen gegevens	8.5% $ 28.3m
Denise Sterling	Executive VP & CFO	1.8yrs	US$593.25k	0.037% $ 124.6k
Todd DuChene	Chief Legal Officer & Chief Administrative Officer	4.8yrs	US$4.53m	0.34% $ 1.1m
Adam Sullivan	CEO & President	less than a year	geen gegevens	geen gegevens
Steven Gitlin	Senior Vice President of Investor Relations	no data	geen gegevens	geen gegevens
Sharon Orlopp	Chief Human Resources Officer	5.5yrs	geen gegevens	geen gegevens
Jeff Taylor	Senior VP & Chief Information Security Officer	no data	geen gegevens	geen gegevens
James Cleveland	Chief Power & Business Development Officer	no data	geen gegevens	geen gegevens
Russell Cann	Executive Vice President of Client Services	7yrs	geen gegevens	geen gegevens
Aaron Mccreery	Senior Vice President of Dev Ops	no data	geen gegevens	geen gegevens
Lynn Burgener	Senior VP of Tax & Trade	5.1yrs	geen gegevens	geen gegevens
Jeff Pratt	Senior Vice President of Partnerships	no data	geen gegevens	geen gegevens

4.9yrs

Gemiddelde duur

53.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van CORZ.Q wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.9 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Darin Feinstein	Co-Founder & Executive VP of Corporate Strategy & Director	2yrs	geen gegevens	8.5% $ 28.3m
Michael Levitt	Chairman	5.6yrs	US$5.81m	6.04% $ 20.1m
Kneeland Youngblood	Independent Director	2yrs	US$190.00k	0.027% $ 89.0k
Jarvis Hollingsworth	Lead Independent Director	2yrs	US$789.80k	0.081% $ 269.7k
Neal Goldman	Independent Director	1.3yrs	US$70.00k	geen gegevens
Matthew Minnis	Independent Director	5.6yrs	geen gegevens	7.78% $ 25.9m

2.0yrs

Gemiddelde duur

59.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CORZ.Q wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2 jaar), wat duidt op een nieuw bestuur.

Core Scientific Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Core Scientific, Inc. Appoints Adam Sullivan as Chief Executive Officer

Core Scientific, Inc. Appoints Adam Sullivan as President

Stacie Olivares Resigns as A Director of Core Scientific, Inc

Core Scientific, Inc. Appoints Todd Duchene as President and Chief Legal Officer, Effective November 14, 2022

Core Scientific, Inc. Announces Management Changes

Co-Founder recently sold US$9.0m worth of stock

Recent updates

Core Scientific, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Core Scientific, Inc. to Report Q2, 2024 Results on Aug 07, 2024

CoreWeave, Inc. cancelled the acquisition of Core Scientific, Inc. (NasdaqGS:CORZ).

Core Scientific, Inc. to Report Q1, 2024 Results on May 08, 2024

Core Scientific, Inc. to Report Fiscal Year 2023 Results on Mar 12, 2024

Core Scientific, Inc. Emerged from Bankruptcy

Core Scientific, Inc. Com Deleted from OTC Equity

Modified Fourth Amended Joint Reorganization Plan and Disclosure Statement Approved for Core Scientific, Inc.

Core Scientific, Inc. has completed a Follow-on Equity Offering in the amount of $55 million.

Amended Reorganization Plan Filed by Core Scientific, Inc.

Core Scientific, Inc. has filed a Follow-on Equity Offering in the amount of $55 million.

Core Scientific, Inc. has filed a Follow-on Equity Offering in the amount of $55 million.

Core Scientific, Inc. announced that it expects to receive $53.9 million in funding from Bitmain Technologies Limited

Core Scientific, Inc. Appoints Adam Sullivan as Chief Executive Officer

Core Scientific, Inc. Appoints Adam Sullivan as President

Core Scientific, Inc. announced delayed 10-Q filing

Core Scientific, Inc.(OTCPK:CORZ.Q) dropped from NASDAQ Composite Index

Core Scientific's Common Stock to Be Delisted from Nasdaq

Core Scientific, Inc. Filed for Bankruptcy

Core Scientific Receives A Written Notice from the Listing Qualifications Staff of Nasdaq Regarding Minimum Bid Price Requirement

Stacie Olivares Resigns as A Director of Core Scientific, Inc

Core Scientific, Inc. Appoints Todd Duchene as President and Chief Legal Officer, Effective November 14, 2022

Core Scientific, Inc. announced delayed 10-Q filing

Core Scientific, Inc Contemplates Bankruptcy

Core Scientific, Inc. Announces Management Changes

Core Scientific: A Solid Bitcoin Mining Play

Core Scientific, Inc. announced delayed 10-Q filing

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Core Scientific, Inc. Announces Impairment Charges for the Second Quarter Ended June 30, 2022

Core Scientific: A Buy On Leading Bitcoin Production Numbers

Core Scientific July bitcoin production rose 10.4% M/M with new deployments and multiple facilities

Core Scientific, Inc. announced that it expects to receive $100 million in funding from B. Riley Principal Capital II, LLC

Core Scientific signs $100M in committed equity facility for enhancing liquidity

Price target decreased to US$8.02

Core Scientific, Inc. to Report Q2, 2022 Results on Aug 11, 2022

Consensus EPS estimates fall by 13%

Why I'm Very Optimistic On Core Scientific's Future

Price target decreased to US$11.00

Co-Founder recently sold US$9.0m worth of stock

Consensus forecasts updated

Core Scientific, Inc. Provides Operating Guidance for the Year 2022

Price target decreased to US$16.19

Investor sentiment deteriorated over the past week

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Investor sentiment deteriorated over the past week

Robust Earnings May Not Tell The Whole Story For Core Scientific (NASDAQ:CORZ)

Core Scientific, Inc. announced that it expects to receive $75 million in funding from B. Riley Commercial Capital, LLC

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd